It is no surprise that technical progress in altering genes precisely, permanently, and safely is driving advances in biotechnology research. Genome editing is the key to delivering on the promise of the human genome project (HGP). Once scientists deduce relationships between genotypes and phenotypes and convert sequencing data into meaningful and actionable biological and clinical insights, genome editing holds the potential to alter errant genetic codes to treat diseases that were once deemed incurable.
